NUTLEY, N.J.--(BUSINESS WIRE)--Roche announced today the introduction of a flexible purchase program that will allow U.S. businesses to maintain access to their own stockpile of Tamiflu® for use in a pandemic situation, with limited upfront investment and more adaptability to deal with unknown factors inherent in pandemic planning.
